About us

Our company

Cooper Consumer Health is a fast growing consumer health company, marketing leading self-medication brands primarily in selected Western European countries and Hong Kong. Cooper Consumer Health is headquartered in Paris, France.

Cooper Consumer Health is the leader in Calming & Sleeping with flagship brand Valdispert, in Beauty from Within with major brand Oenobiol and in Medicated Foot Care with the brand Excilor. Cooper Consumer Health is active in a number of other categories with brands such as Roter and Dagravit.

Cooper Consumer Health manufactures the majority of its products in its GMP licenced manufacturing facility specialized in the production of (film-coated) tablets, sachets and capsules in bottles and blisterpacks. This production facility has also some contract manufacturing activity.


Vemedia was set up by Philips Duphar and Gist Brocades in 1961 initially as a veterinary medicine business and shortly after self-care medication and pesticides were added to the portfolio.

In 2002 Yvan Vindevogel acquired Vemedia from Solvay and during the next decade following an ‘acquisition-and-build strategy’ the group acquired a number of businesses substantially growing sales from its brand portfolio and expanding its geographical presence in Europe and a number of emerging markets. The major milestones included the acquisition of Viatris in 2006 and Valdispert in 2008. In order to finance this growth Vemedia made shares available to to the public.

In order to continue its ambitious growth strategy, Vemedia searched for for a financial partner and in 2012 IK Investment Partners took a substantial share in the Company with Yvan Vindevogel and management becoming minority shareholders.   

At the end of 2012 Vemedia acquired Excilor, a leading OTC brand for the treatment of fungal nail infection. In 2013, under new ownership, Vemedia entered the French market and during that year sold its chemical compounding business allowing Vemedia to become a virtually exclusive over-the-counter company with an extensive portfolio of products.

Early 2016 Vemedia reached an agreement with Sanofi about the acquisition of Oenobiol, an iconic and well known brand in the beauty supplements market. Founded in France and made successful by Marie Béjot, physician and nutritionist. Also in 2016 Labima, a pharmaceutical manufacturer, founded in 1952 in Belgium by Jean Siméons, an industrial pharmacist, was acquired by Vemedia. In the same year Stardea from Italy was added to the Vemedia Group. And ultimately in 2016 Vision Healthcare was added to the Group, with brands such as Vision, Ecosym, Luuf, Glucadol and Inolium.


Cooper Consumer Health continually explores opportunities and innovation in consumer healthcare with specific interest in Cooper's core categories. Significant investment and resource in product innovation is key in order to meet the demands of customer.

We have a dedicated innovation team whose objectives are:

  • To search for innovative active ingredients, technologies & finished products with proven therapeutic benefits
  • Examine existing products to find novel therapeutic targets
  • Optimise galenic forms
  • Develop a portfolio of medical devices, food supplements and OTC ingredients

Cooper Consumer Health is member of the AESGP and participates in various working committees such as the Regulatory Affairs Committee, Advisory Commission for Plant Preparations, Medical Device Working Group and many others.